No Evidence That Higher Doses of Sertraline Cause Thiamine Deficiency
There is no established causal relationship between sertraline at any dose and thiamine deficiency. Neither the FDA drug label for sertraline nor current clinical guidelines identify sertraline as a risk factor for thiamine deficiency 1.
What the Evidence Shows
Sertraline Safety Profile
The FDA-approved labeling for sertraline extensively documents adverse effects including serotonin syndrome, bleeding risk, hyponatremia, and sexual dysfunction, but makes no mention of thiamine deficiency or any micronutrient depletion 1. The most common adverse events are gastrointestinal (nausea, diarrhea), CNS effects (insomnia, somnolence), and sexual dysfunction 2.
Established Risk Factors for Thiamine Deficiency
According to the 2022 ESPEN Micronutrient Guidelines, the recognized risk factors for thiamine deficiency include 3:
- Malnutrition and poor oral intake
- Chronic alcohol consumption (the most common cause)
- Chronic diuretic therapy (particularly loop diuretics)
- Malabsorptive conditions (bariatric surgery, inflammatory bowel disease)
- Prolonged vomiting or refeeding syndrome
- Critical illness (sepsis, major trauma)
- Continuous renal replacement therapy
- Parenteral nutrition without adequate supplementation
Sertraline is conspicuously absent from this comprehensive list.
Recent Research Findings
A 2026 Swedish nationwide study identified a rare association between sertraline and acquired multiple acyl-CoA dehydrogenase deficiency (MADD), a disorder of fatty acid metabolism—not thiamine deficiency 4. This represents a completely different metabolic pathway and should not be confused with thiamine status.
Clinical Implications
When to Suspect Thiamine Deficiency
Consider thiamine deficiency in patients presenting with:
- Neurological symptoms: confusion, ataxia, ophthalmoplegia (Wernicke's encephalopathy), peripheral neuropathy
- Cardiovascular symptoms: heart failure, lactic acidosis (wet beriberi)
- Psychiatric symptoms: apathy, memory impairment, irritability 3
Who Needs Screening
The 2022 ESPEN guidelines recommend measuring RBC or whole blood thiamine diphosphate (ThDP) in 3:
- Patients with cardiomyopathy on prolonged diuretics
- Post-bariatric surgery patients
- Patients with encephalopathy of uncertain etiology
- Refeeding syndrome cases
Routine screening is not recommended for patients on sertraline alone.
Treatment Approach
If thiamine deficiency is identified in a patient taking sertraline, treat according to standard protocols 3:
- Mild deficiency: 10 mg/day orally for 1 week, then 3-5 mg/day for 6 weeks
- Suspected deficiency with risk factors: 100 mg three times daily IV
- Encephalopathy: 500 mg three times daily IV
Do not discontinue sertraline unless there is a separate clinical indication, as it is not contributing to the deficiency.
Common Pitfall to Avoid
Do not attribute thiamine deficiency to sertraline therapy. If a patient on sertraline develops thiamine deficiency, systematically evaluate for the established risk factors listed above—particularly alcohol use, dietary inadequacy, chronic diuretic use, or malabsorptive conditions. The sertraline is coincidental, not causal.
The one documented case report of psychosis responsive to thiamine involved a patient whose symptoms were attributed to thiamine deficiency itself, not to any medication 5. This further reinforces that psychiatric symptoms can result from thiamine deficiency but does not implicate psychiatric medications as causative agents.